UK markets closed

CONMED Corporation (CNMD)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
74.86-0.45 (-0.60%)
At close: 04:00PM EDT
74.86 0.00 (0.00%)
After hours: 04:04PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.32B
Enterprise value 3.28B
Trailing P/E 28.85
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.88
Price/book (mrq)2.71
Enterprise value/revenue 2.60
Enterprise value/EBITDA 15.25

Trading information

Stock price history

Beta (5Y monthly) 1.37
52-week change 3-36.57%
S&P500 52-week change 328.04%
52-week high 3138.47
52-week low 361.05
50-day moving average 374.80
200-day moving average 394.50

Share statistics

Avg vol (3-month) 3527.22k
Avg vol (10-day) 3431.79k
Shares outstanding 530.8M
Implied shares outstanding 630.93M
Float 830.53M
% held by insiders 10.56%
% held by institutions 1117.46%
Shares short (30 Apr 2024) 43.48M
Short ratio (30 Apr 2024) 45.49
Short % of float (30 Apr 2024) 415.69%
Short % of shares outstanding (30 Apr 2024) 411.31%
Shares short (prior month 28 Mar 2024) 44.07M

Dividends & splits

Forward annual dividend rate 40.8
Forward annual dividend yield 41.06%
Trailing annual dividend rate 30.80
Trailing annual dividend yield 31.06%
5-year average dividend yield 40.80
Payout ratio 430.65%
Dividend date 305 Apr 2024
Ex-dividend date 414 Mar 2024
Last split factor 23:2
Last split date 310 Sept 2001

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 6.53%
Operating margin (ttm)9.63%

Management effectiveness

Return on assets (ttm)3.68%
Return on equity (ttm)10.25%

Income statement

Revenue (ttm)1.26B
Revenue per share (ttm)41.05
Quarterly revenue growth (yoy)5.70%
Gross profit (ttm)N/A
EBITDA 206.55M
Net income avi to common (ttm)82.35M
Diluted EPS (ttm)2.61
Quarterly earnings growth (yoy)983.50%

Balance sheet

Total cash (mrq)33.85M
Total cash per share (mrq)1.1
Total debt (mrq)990.8M
Total debt/equity (mrq)115.93%
Current ratio (mrq)2.18
Book value per share (mrq)27.76

Cash flow statement

Operating cash flow (ttm)158.32M
Levered free cash flow (ttm)168.06M